Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Neuroprotection in Pediatric Severe TBI
NCT00556387Phase 2Withdrawn
- Sponsor
- University of Arkansas
- Start
- Dec 2008
- Primary completion
- Dec 2012
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial of ketamine in traumatic brain injury (TBI) (2 arms), sponsored by University of Arkansas. Primary endpoint: Clinical, radiological, and neurodevelopmental outcomes at 1 year. Planned start Dec 2008; status: withdrawn.
02
Drugs
ketamine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT00556387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00556387.